EPISODE · Oct 27, 2020 · 14 MIN
Good Intentions
from Tradeoffs
With communities of color disproportionately impacted by COVID-19, drugmakers and public health officials are placing an unprecedented emphasis on diversity in vaccine clinical trials.Guests:Beau Garland, Vice President of Recruitment, Meridian Clinical ResearchJonathan Jackson, PhD, Director, CARE Research Center, Massachusetts General Hospital.For complete complete transcript of this conversation: https://tradeoffs.org/2020/10/27/good-intentions/To stay on top of all our coverage of the coronavirus and our conversations with people who are being forced to make difficult decisions in the midst of it all, visit http://bit.ly/coronavirustradeoffs.Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
With communities of color disproportionately impacted by COVID-19, drugmakers and public health officials are placing an unprecedented emphasis on diversity in vaccine clinical trials.Guests:Beau Garland, Vice President of Recruitment, Meridian Clinical ResearchJonathan Jackson, PhD, Director, CARE Research Center, Massachusetts General Hospital.For complete complete transcript of this conversation: https://tradeoffs.org/2020/10/27/good-intentions/To stay on top of all our coverage of the coronavirus and our conversations with people who are being forced to make difficult decisions in the midst of it all, visit http://bit.ly/coronavirustradeoffs.Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Good Intentions
No transcript for this episode yet
Similar Episodes
Jun 17, 2026 ·26m
Jun 15, 2026 ·43m
Jun 12, 2026 ·22m
Jun 11, 2026 ·25m